Dr. White Describes The Br-002 Trial In Breast Cancer

Dr. White Describes the BR-002 Trial in Breast Cancer

Dr. White on the BR-002 Trial in Breast Cancer

Targeted Oncology

Dr. White on Relationship Between Multigene Assays and RT in Breast Cancer

Dr. White on the Utility of Ablative Radiotherapy in Metastatic Breast Cancer

Targeted Oncology

Treatment Decision Making for DCIS - Dr. Monica Morrow

New Developments in Breast Radiotherapy

IntraOp Medical Corporation

Advanced Breast Cancer: Challenges in Pathways Development

Pharmacogenomic Testing and Breast Cancer: The Example of Cyp2D6 and Tamoxifen - Dr. Hannah Linden

Optimizing Therapy in HER2+ Disease with Dr. Hope S. Rugo

Total Health | Oncology

Dr. White on Ablative Radiotherapy for Metastatic Breast Cancer

The TARGIT-A Trial of IORT for breast cancer at the 2012 San Antonio Breast Cancer Symposium

3 Year Cancer Survivor - Stage 4 Breast Cancer at 22 #shorts

Dr. White Discusses the Potential to Cure Patients With Metastatic Breast Cancer

Breast Cancer Screening - The Debate

Learn all about PARP inhibitors with Dr Jon Krell, Consultant Medical Oncologist

Ovarian Cancer Action UK

Dr. Larry Anderson First Line Treatments and Side Effects

International Waldenstrom's Macroglobulinemia Foundation

Dr. White on CNS Metastases in HER2+ Breast Cancer

IBIS-2 Breast Cancer Prevention Trial - Dr. Smith

Compass Oncology

Riordan Clinic: Solid Tumors Behave Like Non-healing Wounds

Dr. Wainberg discusses Advances in Chemotherapy for Pancreatic Cancer

HirshbergFoundation